Moderna says booster produces strong antibody response to Omicron

Pharmaceuticals firm says third dose of its Covid vaccine increases antibodies against variant by 37-fold

The pharmaceuticals company Moderna has said a booster dose of its Covid vaccine appeared to protect against the fast-spreading Omicron variant in laboratory testing and that the current version will continue to be its “first line of defence against Omicron”.

The decision to focus on the current vaccine, mRNA-1273, was driven in part by how quickly the variant is spreading. The company plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical trials early next year.

Continue reading...

Coronavirus | The Guardian

Comments

Popular posts from this blog

Vaccine hesitant New Yorkers consider leaving the city as mandates take effect

Coronavirus live news: AstraZeneca reports vaccine shortfall to EU; Sydney hotel quarantine worker tests positive

One in six New York City workers remain unvaccinated after Friday deadline